By Lynn Welch, Founder & Principal Advisor, The Lion’s View
What we’re seeing across enterprise, manufacturing, and healthcare right now is a version of a pattern I’ve watched before: capability outruns the infrastructure built to contain it. The pace of agentic AI deployment is real. The governance infrastructure required to manage it at scale is not keeping up. This is the operational gap our AI governance advisory practice is designed to address.
This isn’t a technology observation. It’s an operational risk assessment.
The Deployment Numbers Are Not Subtle
Gartner projects that 40% of enterprise applications will include task-specific AI agents by the end of 2026. The agentic AI market is tracking toward $45 billion by 2030, from roughly $8.5 billion today. Microsoft’s recent analysis of the manufacturing sector describes 2026 as an inflection point — the year organizations move agents from pilots to production on the plant floor, in real time, within the flow of work.
In healthcare, NVIDIA’s 2026 State of AI survey found that 70% of organizations are actively deploying AI — up from 63% the prior year — and 85% of executives report measurable revenue impact. Drug discovery, radiology, and clinical workflow optimization are no longer pilots. They’re line items with ROI attached.
Reference: NVIDIA State of AI in Healthcare 2026 | Manufacturing Dive: Agentic AI 2026
The Governance Gap That No One Wants to Discuss Publicly
Here’s the operational reality: 94% of organizations report concern that AI sprawl is increasing complexity, technical debt, and security risk. Only a fraction have established centralized governance for agentic systems. PwC’s 2026 AI Performance Study found that AI leaders — the 20% of companies capturing three-quarters of AI’s economic gains — are 1.5 times more likely to have a functioning cross-functional AI governance board than their peers.
What that gap looks like in practice: 97% of organizations that experienced an AI-related security incident lacked proper AI access controls. 63% had no AI governance policies in place at the time of the incident. These aren’t companies that ignored risk — they were deploying AI quickly, as their boards and investors expected them to. They just didn’t build the accountability infrastructure alongside the capability.
Reference: PwC 2026 AI Performance Study | Partnership on AI: Six Governance Priorities 2026
August 2026: A Hard Deadline That Most Boards Aren’t Ready For
For organizations with EU market exposure, the governance window is closing. The EU AI Act’s high-risk obligations become fully enforceable on August 2, 2026. Conformity assessments completed. Technical documentation finalized. CE marking affixed. EU database registration for high-risk systems in place. Violations carry fines of up to €35 million or 7% of global annual turnover.
What I’m seeing in advisory conversations: organizations at very different stages of readiness, with many still operating under the assumption that their legal team has it handled. In most cases, legal has the compliance checklist. What they don’t have is operational visibility into the AI systems actually running. For federal agencies and defense organizations navigating these obligations, our government and public sector advisory provides the specific operational framework. — where models are deployed, what data they’re ingesting, which outputs are informing regulated decisions. That’s not a legal problem. That’s an operational accountability gap.
Reference: Orrick: 6 Steps Before August 2, 2026 | EU AI Act 2026 Compliance Requirements
What Decision-Makers Are Missing Right Now
The organizations falling behind aren’t the ones that failed to invest in AI. They invested. They deployed. The problem is structural: governance was treated as a compliance function rather than an operating function. You can’t audit your way to accountability after an incident. The window to build accountability architecture is before the agent fleet scales.
Three things that tend to be missing when I walk into an organization that’s deploying AI at scale without adequate governance:
First, an accurate inventory of AI systems in production — including systems deployed by business units without central IT visibility. Shadow AI is the norm in enterprise environments, not the exception.
Second, a defined human oversight protocol for AI outputs that inform regulated, high-stakes, or irreversible decisions. In healthcare, these stakes carry direct clinical implications — explored in depth in our analysis of scaling healthcare AI from pilot to production. The EU AI Act is explicit on this. So are the liability questions that will follow the first significant AI-related operational failure in a regulated sector.
Third, board-level literacy sufficient to ask the right questions. PwC found that directors on industrial boards are the least confident of any sector in their readiness to oversee AI. That’s not a technology literacy problem. That’s a governance maturity problem — and it’s addressable.
Where This Goes From Here
The 20% of organizations capturing three-quarters of AI’s economic returns share a pattern: they built governance infrastructure alongside capability. Not instead of it. Not after the fact. Alongside it. That’s the strategic distinction that’s widening into a structural competitive advantage.
The next twelve months will produce the first wave of high-profile AI-related incidents in regulated industries — healthcare, finance, defense supply chain — where the governance gap becomes a liability event. Organizations that have already built the accountability infrastructure will be positioned to move faster, not slower, in the aftermath. Everyone else will be in remediation mode.
The operational window to act is now. Not because the deadline says so. Because the fleet is already deployed.
Lynn Welch is Founder and Principal Advisor at The Lion’s View, an independent AI and extended reality advisory firm serving PE/investment firms, enterprise and healthcare organizations, and defense/government agencies. The Lion’s View provides vendor-neutral, operator-credible advisory services to decision-makers navigating AI investment, governance, and deployment decisions.
Contact: thelionsview.com | lynn@thelionsview.com
Comments are closed